About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2012 (2012), Article ID 964862, 15 pages
http://dx.doi.org/10.6064/2012/964862
Review Article

Tissue Factor Structure and Function

Department of Biochemistry, University of Vermont, 208 South Park Drive, Room 235A, Colchester, VT 05446, USA

Received 30 October 2012; Accepted 19 November 2012

Academic Editors: P. Auberger, F. Giona, and R. Schwendener

Copyright © 2012 Saulius Butenas. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Lawson, S. Butenas, and K. G. Mann, “The evaluation of complex-dependent alterations in human factor VIIa,” Journal of Biological Chemistry, vol. 267, no. 7, pp. 4834–4843, 1992. View at Scopus
  2. N. Mackman, “Role of tissue factor in hemostasis, thrombosis, and vascular development,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 6, pp. 1015–1022, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Butenas and K. G. Mann, “Active tissue factor in blood?” Nature Medicine, vol. 10, pp. 1155–1156, 2004.
  4. J. H. Morrissey, B. G. Macik, P. F. Neuenschwander, and P. C. Comp, “Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation,” Blood, vol. 81, no. 3, pp. 734–744, 1993. View at Scopus
  5. J. H. Lawson, S. Butenas, N. Ribarik, and K. G. Mann, “Complex-dependent inhibition of factor VIIa by antithrombin III and heparin,” Journal of Biological Chemistry, vol. 268, no. 2, pp. 767–770, 1993. View at Scopus
  6. K. G. Mann, T. Orfeo, S. Butenas, A. Undas, and K. Brummel-Ziedins, “Blood coagulation dynamics in haemostasis,” Hamostaseologie, vol. 29, no. 1, pp. 7–16, 2009. View at Scopus
  7. S. Butenas and K. G. Mann, “Blood coagulation,” Biochemistry, vol. 67, no. 1, pp. 3–12, 2002. View at Scopus
  8. K. Brummel-Ziedins, T. Orfeo, N. S. Jenny, S. J. Everse, and K. G. Mann, “Blood coagulation and fibrinolysis,” in Wintrobe'S Clinical Hematology, J. P. Greer, J. Foerster, G. M. Rodgers, et al., Eds., pp. 677–774, Lippincott, Williams & Wilkins, Philadelphia, Pa, USA, 2004.
  9. S. Butenas, T. Orfeo, K. E. Brummel-Ziedins, and K. G. Mann, “Tissue factor in thrombosis and hemorrhage,” Surgery, vol. 142, no. 4, pp. S2–S14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Krudysz-Amblo, M. E. Jennings, D. E. Matthews, K. G. Mann, and S. Butenas, “Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor,” Biochimica et Biophysica Acta, vol. 1810, no. 4, pp. 398–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Butenas, B. A. Bouchard, K. E. Brummel-Ziedins, B. Parhami-Seren, and K. G. Mann, “Tissue factor activity in whole blood,” Blood, vol. 105, no. 7, pp. 2764–2770, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Krudysz-Amblo, M. E. Jennings, K. G. Mann, and S. Butenas, “Carbohydrates and activity of natural and recombinant tissue factor,” Journal of Biological Chemistry, vol. 285, no. 5, pp. 3371–3382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. H. Seegers, “Activation of purified prothrombin,” Proceedings of the Society for Experimental Biology and Medicine, vol. 72, pp. 677–680, 1949.
  14. K. G. Mann, M. E. Nesheim, K. R. Church, P. Haley, and S. Krishnaswamy, “Surface-dependent reactions of the vitamin K-dependent enzyme complexes,” Blood, vol. 76, no. 1, pp. 1–16, 1990. View at Scopus
  15. Y. Komiyama, A. H. Pedersen, and W. Kisiel, “Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor,” Biochemistry, vol. 29, no. 40, pp. 9418–9425, 1990. View at Scopus
  16. V. J. J. Bom and R. M. Bertina, “The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII,” Biochemical Journal, vol. 265, no. 2, pp. 327–336, 1990. View at Scopus
  17. K. G. Mann, S. Krishnaswamy, and J. H. Lawson, “Surface-dependent hemostasis,” Seminars in Hematology, vol. 29, no. 3, pp. 213–226, 1992. View at Scopus
  18. M. E. Nesheim, J. B. Taswell, and K. G. Mann, “The contribution of bovine factor V and factor Va to the activity of prothrombinase,” Journal of Biological Chemistry, vol. 254, no. 21, pp. 10952–10962, 1979. View at Scopus
  19. P. B. Tracy, M. E. Nesheim, and K. G. Mann, “Coordinate binding of factor Va and factor Xa to the unstimulated platelet,” Journal of Biological Chemistry, vol. 256, no. 2, pp. 743–751, 1981. View at Scopus
  20. B. J. Lamphear and P. J. Fay, “Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer,” Journal of Biological Chemistry, vol. 267, no. 6, pp. 3725–3730, 1992. View at Scopus
  21. G. L. Nelsestuen, W. Kisiel, and R. G. Di Scipio, “Interaction of vitamin K dependent proteins with membranes,” Biochemistry, vol. 17, no. 11, pp. 2134–2138, 1978. View at Scopus
  22. C. Mills, “Chemical nature of tissue coagulins,” Biochemistry, vol. 46, pp. 135–165, 1921.
  23. L. Wooldridge, On the Chemistry of the Blood and other Scientific Papers, Edited by L. Wooldridge, London, UK, 1893.
  24. E. Camerer, A. B. Kolstø, and H. Prydz, “Cell biology of tissue factor, the principal initiator of blood coagulation,” Thrombosis Research, vol. 81, no. 1, pp. 1–41, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Howell, “The nature and action of the thromboplastic (zymoplastic) substance of the tissues,” American Journal of Physiology, vol. 31, pp. 1–21, 1912.
  26. R. Bach, Y. Nemerson, and W. Konigsberg, “Purification and characterization of bovine tissue factor,” Journal of Biological Chemistry, vol. 256, no. 16, pp. 8324–8331, 1981. View at Scopus
  27. E. K. Spicer, R. Horton, and L. Bloem, “Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 15, pp. 5148–5152, 1987. View at Scopus
  28. N. Mackman, “The many faces of tissue factor,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 136–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Ruf, A. Rehemtulla, J. H. Morrissey, and T. S. Edgington, “Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function,” The Journal of Biological Chemistry, vol. 266, pp. 2158–2166, 1991.
  30. M. M. Fiore, P. F. Neuenschwander, and J. H. Morrissey, “The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa,” Journal of Biological Chemistry, vol. 269, no. 1, pp. 143–149, 1994. View at Scopus
  31. J. Ahamed and W. Ruf, “Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain,” Journal of Biological Chemistry, vol. 279, no. 22, pp. 23038–23044, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Siegbahn, M. Johnell, B. B. Sorensen, L. C. Petersen, and C. H. Heldin, “Regulation of chemotaxis by the cytoplasmic domain of tissue factor,” Thrombosis and Haemostasis, vol. 93, no. 1, pp. 27–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. E. W. Collier and C. Ettelaie, “Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor,” Journal of Biological Chemistry, vol. 286, no. 14, pp. 11977–11984, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. R. Toomey, K. J. Smith, and D. W. Stafford, “Localization of the human tissue factor recognition determinant of human factor VIIa,” Journal of Biological Chemistry, vol. 266, no. 29, pp. 19198–19202, 1991. View at Scopus
  35. J. R. Schullek, W. Ruf, and T. S. Edgington, “Key ligand interface residues in tissue factor contribute independently to factor VIIa binding,” Journal of Biological Chemistry, vol. 269, no. 30, pp. 19399–19403, 1994. View at Scopus
  36. S. Butenas, N. Ribarik, and K. G. Mann, “Synthetic substrates for human factor VIIa and factor VIIa-tissue factor,” Biochemistry, vol. 32, no. 26, pp. 6531–6538, 1993. View at Scopus
  37. E. M. Scarpati, D. Wen, G. J. Broze et al., “Human tissue factor: cDNA sequence and chromosome localization of the gene,” Biochemistry, vol. 26, no. 17, pp. 5234–5238, 1987. View at Scopus
  38. F. T. Kao, J. Hartz, R. Horton, Y. Nemerson, and S. D. Carson, “Regional assignment of human tissue factor gene (F3) to chromosome 1p21-p22,” Somatic Cell and Molecular Genetics, vol. 14, no. 4, pp. 407–410, 1988. View at Scopus
  39. J. H. Morrissey, H. Fakhrai, and T. S. Edgington, “Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade,” Cell, vol. 50, no. 1, pp. 129–135, 1987. View at Scopus
  40. K. L. Fisher, C. M. Gorman, G. A. Vehar, D. P. O'Brien, and R. M. Lawn, “Cloning and expression of human tissue factor cDNA,” Thrombosis Research, vol. 48, no. 1, pp. 89–99, 1987. View at Scopus
  41. N. Mackman, J. H. Morrissey, B. Fowler, and T. S. Edgington, “Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade,” Biochemistry, vol. 28, no. 4, pp. 1755–1762, 1989. View at Scopus
  42. J. F. Bazan, “Structural design and molecular evolution of a cytokine receptor superfamily,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 18, pp. 6934–6938, 1990. View at Scopus
  43. A. M. de Vos, M. Ultsch, and A. A. Kossiakoff, “Human growth hormone and extracellular domain of its receptor: crystal structure of the complex,” Science, vol. 255, no. 5042, pp. 306–312, 1992. View at Scopus
  44. W. Somers, M. Ultsch, A. M. De Vos, and A. A. Kossiakoff, “The X-ray structure of growth hormone-prolactin receptor complex,” Nature, vol. 372, no. 6505, pp. 478–481, 1994. View at Publisher · View at Google Scholar · View at Scopus
  45. O. Livnah, E. A. Stura, D. L. Johnson et al., “Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 Å,” Science, vol. 273, no. 5274, pp. 464–471, 1996. View at Scopus
  46. M. R. Walter, W. T. Windsor, T. L. Nagabhushan et al., “Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor,” Nature, vol. 376, no. 6537, pp. 230–235, 1995. View at Scopus
  47. D. L. Bodian, E. Y. Jones, K. Harlos, D. I. Stuart, and S. J. Davis, “Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5Å resolution,” Structure, vol. 2, no. 8, pp. 755–766, 1994. View at Scopus
  48. K. Harlos, D. M. A. Martin, D. P. O'Brien et al., “Crystal structure of the extracellular region of human tissue factor,” Nature, vol. 370, no. 6499, pp. 662–666, 1994. View at Scopus
  49. M. Baron, A. L. Main, P. C. Driscoll, H. J. Mardon, J. Boyd, and L. D. Campbell, “1H NMR assignment and secondary structure of the cell adhesion type III module of fibronectint,” Biochemistry, vol. 31, no. 7, pp. 2068–2073, 1992. View at Scopus
  50. D. C. Dean, C. L. Bowlus, and S. Bourgeois, “Cloning and analysis of the promoter region of the human fibronectin gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 7, pp. 1876–1880, 1987. View at Scopus
  51. A. L. Main, T. S. Harvey, M. Baron, J. Boyd, and I. D. Campbell, “The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions,” Cell, vol. 71, no. 4, pp. 671–678, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. A. Muller, M. H. Ultsch, and A. M. De Vos, “The crystal structure of the extracellular domain of human tissue factor refined to 1.7 Å resolution,” Journal of Molecular Biology, vol. 256, no. 1, pp. 144–159, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. M. P. Peppelenbosch and H. H. Versteeg, “Cell biology of tissue factor, an unusual member of the cytokine receptor family,” Trends in Cardiovascular Medicine, vol. 11, no. 8, pp. 335–339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  54. B. A. Bouchard, M. A. Shatos, and P. B. Tracy, “Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 1, pp. 1–9, 1997. View at Scopus
  55. A. D. Schecter, B. Spirn, M. Rossikhina et al., “Release of active tissue factor by human arterial smooth muscle cells,” Circulation Research, vol. 87, no. 2, pp. 126–132, 2000. View at Scopus
  56. C. Flossel, T. Luther, M. Muller, S. Albrecht, and M. Kasper, “Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue,” Histochemistry, vol. 101, no. 6, pp. 449–453, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. T. A. Drake, J. H. Morissey, and T. S. Edgington, “Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis,” American Journal of Pathology, vol. 134, no. 5, pp. 1087–1097, 1989. View at Scopus
  58. R. A. Fleck, L. V. M. Rao, S. I. Rapaport, and N. Varki, “Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody,” Thrombosis Research, vol. 59, no. 2, pp. 421–437, 1990. View at Scopus
  59. M. Eddleston, J. C. de la Torre, M. B. A. Oldstone, D. J. Loskutoff, T. S. Edgington, and N. Mackman, “Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis,” Journal of Clinical Investigation, vol. 92, no. 1, pp. 349–358, 1993. View at Scopus
  60. L. J. Bloem, L. Chen, W. H. Konigsberg, and R. Bach, “Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity,” Journal of Cellular Physiology, vol. 139, no. 2, pp. 418–423, 1989. View at Scopus
  61. M. Levi, T. van der Poll, and H. Ten Cate, “Tissue factor in infection and severe inflammation,” Seminars in Thrombosis and Hemostasis, vol. 32, no. 1, pp. 33–39, 2006. View at Scopus
  62. B. A. Bouchard and P. B. Tracy, “The participation of leukocytes in coagulant reactions,” Journal of Thrombosis and Haemostasis, vol. 1, no. 3, pp. 464–469, 2003. View at Scopus
  63. M. Nijziel, R. Van Oerle, C. Van't Veer, E. Van Pampus, T. Lindhout, and K. Hamulyák, “Tissue factor activity in human monocytes is regulated by plasma: implications for the high and low responder phenomenon,” British Journal of Haematology, vol. 112, no. 1, pp. 98–104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Broussas, P. Cornillet-Lefèbvre, G. Potron, and P. Nguyên, “Adenosine inhibits tissue factor expression by LPS-stimulated human monocytes: involvement of the A3 adenosine receptor,” Thrombosis and Haemostasis, vol. 88, no. 1, pp. 123–130, 2002. View at Scopus
  65. R. Ando, S. Kase, T. Ohashi et al., “Tissue factor expression in human pterygium,” Molecular Vision, vol. 17, pp. 63–69, 2011. View at Scopus
  66. R. L. Edwards, F. R. Rickles, and M. Cronlund, “Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation,” Journal of Laboratory and Clinical Medicine, vol. 98, no. 6, pp. 917–928, 1981. View at Scopus
  67. W. Ruf and B. M. Mueller, “Thrombin generation and the pathogenesis of cancer,” Seminars in Thrombosis and Hemostasis, vol. 32, supplement 1, pp. 61–68, 2006.
  68. C. López-Pedrera, N. Barbarroja, G. Dorado, E. Siendones, and F. Velasco, “Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies,” Leukemia, vol. 20, no. 8, pp. 1331–1340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. E. Cocco, J. Varughese, N. Buza et al., “Expression of Tissue factor in adenocarcinoma and squamous cell carcinoma of the uerine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFaac chimeric protein targeting tissue factor,” BMC Cancer, vol. 11, article 263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Jude, C. Zawadzki, S. Susen, and D. Corseaux, “Relevance of tissue factor in cardiovascular disease,” Archives des Maladies du Coeur et des Vaisseaux, vol. 98, no. 6, pp. 667–671, 2005. View at Scopus
  71. A. D. Mumford and J. H. McVey, “Tissue Factor in the myocardium: evidence of roles in haemostasis and inflammation,” Disease Markers, vol. 20, no. 6, pp. 353–358, 2004. View at Scopus
  72. B. Ray, I. C. Chetter, H. L. D. Lee, C. Ettelaie, and P. T. McCollum, “Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty,” British Journal of Surgery, vol. 94, no. 9, pp. 1092–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. A. K. So, P. A. Varisco, B. Kemkes-Matthes et al., “Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways,” Journal of Thrombosis and Haemostasis, vol. 1, no. 12, pp. 2510–2515, 2003. View at Scopus
  74. R. A. Santucci, J. Erlich, J. Labriola et al., “Measurement at tissue factor activity in whole blood,” Thrombosis and Haemostasis, vol. 83, no. 3, pp. 445–454, 2000. View at Scopus
  75. R. J. Berckmans, R. Nieuwland, A. N. Böing, F. P. H. T. M. Romijn, C. E. Hack, and A. Sturk, “Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation,” Thrombosis and Haemostasis, vol. 85, no. 4, pp. 639–646, 2001. View at Scopus
  76. M. D. Rand, J. B. Lock, C. Van't Veer, D. P. Gaffney, and K. G. Mann, “Blood clotting in minimally altered whole blood,” Blood, vol. 88, no. 9, pp. 3432–3445, 1996. View at Scopus
  77. K. M. Cawthern, C. Van't Veer, J. B. Lock, M. E. DiLorenzo, R. F. Branda, and K. G. Mann, “Blood coagulation in hemophilia A and hemophilia C,” Blood, vol. 91, no. 12, pp. 4581–4592, 1998. View at Scopus
  78. V. Peyrou, J. C. Lormeau, J. P. Hérault, C. Gaich, A. M. Pfliegger, and J. M. Herbert, “Contribution of erythrocytes to thrombin generation in whole blood,” Thrombosis and Haemostasis, vol. 81, no. 3, pp. 400–406, 1999. View at Scopus
  79. R. He, S. Xiong, X. He et al., “The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway,” Thrombosis and Haemostasis, vol. 85, no. 6, pp. 1055–1059, 2001. View at Scopus
  80. I. M. L. W. Keularts, A. Zivelin, U. Seligsohn, H. Coenraad Hemker, and S. Béguin, “The role of factor XI in thrombin generation induced by low concentrations of tissue factor,” Thrombosis and Haemostasis, vol. 85, no. 6, pp. 1060–1065, 2001. View at Scopus
  81. S. A. Gregory, J. H. Morrissey, and T. S. Edgington, “Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin,” Molecular and Cellular Biology, vol. 9, no. 6, pp. 2752–2755, 1989. View at Scopus
  82. R. F. Franco, E. De Jonge, P. E. P. Dekkers et al., “The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation,” Blood, vol. 96, no. 2, pp. 554–559, 2000. View at Scopus
  83. E. M. Egorina, M. A. Sovershaev, G. Bjørkøy et al., “Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1493–1498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. A. P. Owens III, F. H. Passam, S. Antoniak, S. M. Marshall, A. L. McDaniel, L. Rudel, et al., “Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin,” The Journal of Clinical Investigation, vol. 122, pp. 558–568, 2012.
  85. S. R. Meisel, X. P. Xu, T. S. Edgington et al., “Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein,” Journal of Atherosclerosis and Thrombosis, vol. 18, no. 7, pp. 596–603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. C. T. Esmon, K. Fukudome, T. Mather et al., “Inflammation, sepsis, and coagulation,” Haematologica, vol. 84, no. 3, pp. 254–259, 1999. View at Scopus
  87. C. Christersson, M. Johnell, and A. Siegbahn, “Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10,” Journal of Thrombosis and Haemostasis, vol. 6, no. 6, pp. 986–994, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. M. A. Sovershaev, E. M. Egorina, B. Osterud, and J. B. Hansen, “Evidence for direct transfer of tissue factor from monocytes to platelets in whole blood,” Blood Coagulation & Fibrinolysis, vol. 23, pp. 345–350, 2012.
  89. M. Hayashi, K. Takeshita, Y. Inden, et al., “Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction,” Thrombosis Research, vol. 128, pp. e113–e118, 2011.
  90. A. Zillmann, T. Luther, I. Müller et al., “Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation,” Biochemical and Biophysical Research Communications, vol. 281, no. 2, pp. 603–609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  91. I. Müller, A. Klocke, M. Alex et al., “Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets,” The FASEB Journal, vol. 17, no. 3, pp. 476–478, 2003. View at Scopus
  92. O. Panes, V. Matus, C. G. Sáez, T. Quiroga, J. Pereira, and D. Mezzano, “Human platelets synthesize and express functional tissue factor,” Blood, vol. 109, no. 12, pp. 5242–5250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Schwertz, N. D. Tolley, J. M. Foulks et al., “Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets,” Journal of Experimental Medicine, vol. 203, no. 11, pp. 2433–2440, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. M. Camera, M. Frigerio, V. Toschi et al., “Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1690–1696, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Camera, M. Brambilla, L. Facchinetti, et al., “Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF,” Thrombosis Research, vol. 129, pp. 279–284, 2012.
  96. M. Brambilla, M. Camera, D. Colnago et al., “Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 947–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. B. A. Bouchard, K. G. Mann, and S. Butenas, “No evidence for tissue factor on platelets,” Blood, vol. 116, no. 5, pp. 854–855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. B. Osterud and E. Bjorklid, “Sources of tissue factor,” Seminars in Thrombosis and Hemostasis, vol. 32, pp. 11–23, 2006.
  99. B. Osterud and E. Bjorklid, “Tissue factor in blood cells and endothelial cells,” Frontiers in Bioscience, vol. 4, pp. 289–299, 2012.
  100. M. Camera, M. Brambilla, V. Toschi, and E. Tremoli, “Tissue factor expression on platelets is a dynamic event,” Blood, vol. 116, no. 23, pp. 5076–5077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. B. A. Bouchard, J. Krudysz-Amblo, and S. Butenas, “Platelet tissue factor is not expressed transiently after platelet activation,” Blood, vol. 119, pp. 4338–4339, 2012.
  102. N. Maugeri, M. Brambilla, M. Camera et al., “Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation,” Journal of Thrombosis and Haemostasis, vol. 4, no. 6, pp. 1323–1330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  103. K. Ritis, M. Doumas, D. Mastellos et al., “A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways,” Journal of Immunology, vol. 177, no. 7, pp. 4794–4802, 2006. View at Scopus
  104. C. Moosbauer, E. Morgenstern, S. L. Cuvelier et al., “Eosinophils are a major intravascular location for tissue factor storage and exposure,” Blood, vol. 109, no. 3, pp. 995–1002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. B. Østerud, L. V. M. Rao, and J. O. Olsen, “Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes,” Thrombosis and Haemostasis, vol. 83, no. 6, pp. 861–867, 2000. View at Scopus
  106. M. A. Sovershaev, K. F. Lind, H. Devold et al., “No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils,” Journal of Thrombosis and Haemostasis, vol. 6, no. 10, pp. 1742–1749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. B. Østerud, “The role of platelets in decrypting monocyte tissue factor,” Seminars in Hematology, vol. 38, no. 4, pp. 2–5, 2001. View at Scopus
  108. J. M. Freyssinet and F. Toti, “Formation of procoagulant microparticles and properties,” Thrombosis Research, vol. 125, supplement 1, pp. S46–S48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  109. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  110. M. M. Aleman, C. Gardiner, P. Harrison, and A. S. Wolberg, “Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability,” Journal of Thrombosis and Haemostasis, vol. 9, pp. 2251–2261, 2011.
  111. M. G. Basavaraj, S. K. Braekkan, E. Brodin, B. Osterud, and J. B. Hansen, “Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromso study,” Journal of Thrombosis and Haemostasis, vol. 9, pp. 1673–1676, 2011.
  112. E. S. Breimo and B. Østerud, “Generation of tissue factor-rich microparticles in an ex vivo whole blood model,” Blood Coagulation and Fibrinolysis, vol. 16, no. 6, pp. 399–405, 2005. View at Scopus
  113. F. Mobarrez, J. Antovic, N. Egberg et al., “A multicolor flow cytometric assay for measurement of platelet-derived microparticles,” Thrombosis Research, vol. 125, no. 3, pp. e110–e116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. B. Osterud, “Tissue factor expression in blood cells,” Thrombosis Research, vol. 125, supplement 1, pp. S31–S34, 2010.
  115. N. S. Key, “Analysis of tissue factor positive microparticles,” Thrombosis Research, vol. 125, supplement 1, pp. S42–S45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. P. Garcia Rodriguez, H. C. J. Eikenboom, M. E. T. Tesselaar et al., “Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism,” Thrombosis Research, vol. 126, no. 4, pp. 345–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. B. A. L. Owen, A. Xue, J. A. Heit, and W. G. Owen, “Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism,” Thrombosis Research, vol. 127, no. 1, pp. 39–46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. F. Langer, B. Spath, K. Haubold et al., “Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation,” Annals of Hematology, vol. 87, pp. 451–457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. D. A. Manly, J. Wang, S. L. Glover et al., “Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism,” Thrombosis Research, vol. 125, no. 6, pp. 511–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. E. Campello, L. Spiezia, C. M. Radu et al., “Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism,” Thrombosis Research, vol. 127, no. 5, pp. 473–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. J. J. A. Auwerda, Y. Yuana, S. Osanto et al., “Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma,” Thrombosis and Haemostasis, vol. 105, no. 1, pp. 14–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. K. Haubold, M. Rink, B. Spath et al., “Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer,” Thrombosis and Haemostasis, vol. 101, no. 6, pp. 1147–1155, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. P. L. Gross and N. Vaezzadeh, “Tissue factor microparticles and haemophilia,” Thrombosis Research, vol. 125, supplement 1, pp. S67–S69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. V. Y. Bogdanov, V. Balasubramanian, J. Hathcock, O. Vele, M. Lieb, and Y. Nemerson, “Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein,” Nature Medicine, vol. 9, no. 4, pp. 458–462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  125. P. Censarek, A. Bobbe, M. Grandoch, K. Schrör, and A. A. Weber, “Alternatively spliced human tissue (asHTF) is not pro-coagulant,” Thrombosis and Haemostasis, vol. 97, no. 1, pp. 11–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. J. E. Hobbs, A. Zakarija, D. L. Cundiff et al., “Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model,” Thrombosis Research, vol. 120, supplement 2, pp. S13–S21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. A. N. Böing, C. M. Hau, A. Sturk, and R. Nieuwland, “Human alternatively spliced tissue factor is not secreted and does not trigger coagulation,” Journal of Thrombosis and Haemostasis, vol. 7, no. 8, pp. 1423–1426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. B. Szotowski, S. Antoniak, W. Poller, H. P. Schultheiss, and U. Rauch, “Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines,” Circulation Research, vol. 96, no. 12, pp. 1233–1239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  129. U. Boltzen, A. Eisenreich, S. Antoniak, et al., “Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-alpha-induced apoptosis,” Journal of Molecular and Cellular Cardiology, vol. 52, pp. 1056–1065, 2012.
  130. Y. W. van den Berg, L. G. van den Hengel, H. R. Myers et al., “Alternatively spliced tissue factor induces angiogenesis through integrin ligation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 46, pp. 19497–19502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  131. R. C. Godby, Y. W. Van Den Berg, R. Srinivasan, et al., “Nonproteolytic properties of murine alternatively spliced tissue factor: implications for integrin-mediated signaling in murine models,” Molecular Medicine, vol. 18, pp. 771–779, 2012.
  132. Y. W. van den Berg and H. H. Versteeg, “Alternatively spliced tissue factor: a crippled protein in coagulation or a key player in non-haemostatic processes?” Hamostaseologie, vol. 30, no. 3, pp. 144–149, 2010. View at Scopus
  133. M. M. H. Khan, T. Hattori, S. Niewiarowski, L. H. Edmunds, and R. W. Colman, “Truncated and microparticle-free soluble tissue factor bound to peripheral monocytes preferentially activate factor VII,” Thrombosis and Haemostasis, vol. 95, no. 3, pp. 462–468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. B. Østerud, E. S. Breimo, and J. O. Olsen, “Blood borne tissue factor revisited,” Thrombosis Research, vol. 122, no. 3, pp. 432–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. B. Parhami-Seren, S. Butenas, J. Krudysz-Amblo, and K. G. Mann, “Immunologic quantitation of tissue factors,” Journal of Thrombosis and Haemostasis, vol. 4, no. 8, pp. 1747–1755, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. V. Y. Bogdanov, G. Cimmino, J. G. Tardos, J. R. Tunstead, and J. J. Badimon, “Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay,” Journal of Thrombosis and Haemostasis, vol. 7, no. 5, pp. 894–897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Bis, J. Vojacek, J. Dusek, et al., “Time-course of tissue factor plasma level in patients with acute coronary syndrome,” Physiological Research, vol. 58, pp. 661–667, 2009.
  138. S. Butenas, A. Undas, M. T. Gissel, K. Szuldrzynski, K. Zmudka, and K. G. Mann, “Factor Xla and tissue factor activity in patients with coronary artery disease,” Thrombosis and Haemostasis, vol. 99, no. 1, pp. 142–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. L. R. Paborsky, K. M. Tate, R. J. Harris et al., “Purification of recombinant human tissue factor,” Biochemistry, vol. 28, no. 20, pp. 8072–8077, 1989. View at Scopus
  140. E. Waxman, J. B. A. Ross, T. M. Laue et al., “Tissue factor and its extracellular soluble domain: the relationship between intermolecular association with factor VIIa and enzymatic activity of the complex,” Biochemistry, vol. 31, no. 16, pp. 3998–4003, 1992. View at Publisher · View at Google Scholar · View at Scopus
  141. L. R. Paborsky and R. J. Harris, “Post-translational modifications of recombinant human tissue factor,” Thrombosis Research, vol. 60, no. 5, pp. 367–376, 1990. View at Publisher · View at Google Scholar · View at Scopus
  142. E. Chargaff, A. Bendich, and S. Cohen, “The thromboplastic protein: structure, properties, disintegration,” Journal of Biological Chemistry, vol. 156, pp. 161–178, 1944.
  143. E. Bjorklid and E. Storm, “Purification and some properties of the protein component of tissue thromboplastin from human brain,” Biochemical Journal, vol. 165, no. 1, pp. 89–96, 1977. View at Scopus
  144. F. R. Rickles, J. Contrino, and D. L. Kreutzer, “Tissue factor expression in normal and abnormal mammary gland—reply,” Nature Medicine, vol. 2, pp. 491–492, 1996.
  145. M. J. Stone, W. Ruf, D. J. Miles, T. S. Edgington, and P. E. Wright, “Recombinant soluble human tissue factor secreted by Saccharomyces cerevisiae and refolded from Escherichia coli inclusion bodies: glycosylation of mutants, activity and physical characterization,” Biochemical Journal, vol. 310, no. 2, pp. 605–614, 1995. View at Scopus
  146. F. A. Pitlick, “Concanavalin A inhibits tissue factor coagulant activity,” Journal of Clinical Investigation, vol. 55, no. 1, pp. 175–179, 1975. View at Scopus
  147. J. W. Shands Jr., “Macrophage factor X activator formation: metabolic requirements for synthesis of components,” Blood, vol. 65, no. 1, pp. 169–175, 1985. View at Scopus
  148. R. Bona, E. Lee, and F. Rickles, “Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles,” Thrombosis Research, vol. 48, no. 4, pp. 487–500, 1987. View at Scopus
  149. P. Cohen, “The role of protein phosphorylation in neural and hormonal control of cellular activity,” Nature, vol. 296, no. 5858, pp. 613–620, 1982. View at Scopus
  150. T. F. Zioncheck, S. Roy, and G. A. Vehar, “The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism,” Journal of Biological Chemistry, vol. 267, no. 6, pp. 3561–3564, 1992. View at Scopus
  151. R. S. Mody and S. D. Carson, “Tissue factor cytoplasmic domain peptide is multiply phosphorylated in vitro,” Biochemistry, vol. 36, no. 25, pp. 7869–7875, 1997. View at Publisher · View at Google Scholar · View at Scopus
  152. A. Dorfleutner and W. Ruf, “Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation,” Blood, vol. 102, no. 12, pp. 3998–4005, 2003. View at Publisher · View at Google Scholar · View at Scopus
  153. B. D. Car, D. O. Slauson, M. Dore, and M. M. Suyemoto, “Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation,” Inflammation, vol. 14, no. 6, pp. 681–689, 1990. View at Publisher · View at Google Scholar · View at Scopus
  154. Y. Nishizuka, “Studies and perspectives of protein kinase C,” Science, vol. 233, no. 4761, pp. 305–312, 1986. View at Scopus
  155. H. H. Versteeg, I. Hoedemaeker, S. H. Diks et al., “Factor VIIa/tissue factor-induced signaling via activation of src-like kinases, phosphatidylinositol 3-kinase, and Rac,” Journal of Biological Chemistry, vol. 275, no. 37, pp. 28750–28756, 2000. View at Scopus
  156. L. K. Poulsen, N. Jacobsen, B. B. Sørensen et al., “Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor,” Journal of Biological Chemistry, vol. 273, no. 11, pp. 6228–6232, 1998. View at Publisher · View at Google Scholar · View at Scopus
  157. L. Rydén, D. Grabau, F. Schaffner, P. E. Jönsson, W. Ruf, and M. Belting, “Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer,” International Journal of Cancer, vol. 126, no. 10, pp. 2330–2340, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. A. I. Magee and S. A. Courtneidge, “Two classes of fatty acid acylated proteins exist in eukaryotic cells,” The EMBO Journal, vol. 4, no. 5, pp. 1137–1144, 1985. View at Scopus
  159. R. Schroeder, E. London, and D. Brown, “Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 25, pp. 12130–12134, 1994. View at Publisher · View at Google Scholar · View at Scopus
  160. R. Bach, W. H. Konigsberg, and Y. Nemerson, “Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine,” Biochemistry, vol. 27, no. 12, pp. 4227–4231, 1988. View at Scopus
  161. G. J. Broze Jr., J. E. Leykam, B. D. Schwartz, and J. P. Miletich, “Purification of human brain tissue factor,” Journal of Biological Chemistry, vol. 260, no. 20, pp. 10917–10920, 1985. View at Scopus
  162. A. Guha, R. Bach, W. Konigsberg, and Y. Nemerson, “Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 2, pp. 299–302, 1986. View at Scopus
  163. S. D. Carson, S. E. Ross, and R. A. Gramzinski, “Protein co-isolated with human tissue factor impairs recovery of activity,” Blood, vol. 71, no. 2, pp. 520–523, 1988. View at Scopus
  164. M. Edidin, “The state of lipid rafts: from model membranes to cells,” Annual Review of Biophysics and Biomolecular Structure, vol. 32, pp. 257–283, 2003.
  165. J. P. Fortin, G. E. Rivard, A. Adam, and F. Marceau, “Studies on rabbit natural and recombinant tissue factors: intracellular retention and regulation of surface expression in cultured cells,” American Journal of Physiology, vol. 288, no. 5, pp. H2192–H2202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. S. K. Mandal, U. R. Pendurthi, and L. V. M. Rao, “Cellular localization and trafficking of tissue factor,” Blood, vol. 107, no. 12, pp. 4746–4753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  167. J. R. Sevinsky, L. V. Mohan Rao, and W. Ruf, “Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway,” Journal of Cell Biology, vol. 133, no. 2, pp. 293–304, 1996. View at Publisher · View at Google Scholar · View at Scopus
  168. S. K. Mandal, A. Iakhiaev, U. R. Pendurthi, and L. V. M. Rao, “Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol,” Blood, vol. 105, no. 1, pp. 153–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  169. D. J. Dietzen, K. L. Page, and T. A. Tetzloff, “Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity,” Blood, vol. 103, no. 8, pp. 3038–3044, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. I. Del Conde, C. N. Shrimpton, P. Thiagarajan, and J. A. López, “Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation,” Blood, vol. 106, no. 5, pp. 1604–1611, 2005. View at Publisher · View at Google Scholar · View at Scopus
  171. L. V. M. Rao and U. R. Pendurthi, “Regulation of tissue factor coagulant activity on cell surfaces,” Journal of Thrombosis and Haemostasis, vol. 10, pp. 2242–2253, 2012.
  172. R. R. Bach, “Tissue factor encryption,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, pp. 456–461, 2006.
  173. W. Ruf, A. Rehemtulla, D. J. Miles, and T. S. Edgington, “The integrity of the cysteine 186-cysteine 209 bond of the second disulfide loop of tissue factor is required for binding of factor VII,” Journal of Biological Chemistry, vol. 266, no. 16, pp. 10294–10299, 1991. View at Scopus
  174. V. M. Chen, J. Ahamed, H. H. Versteeg, M. C. Berndt, W. Ruf, and P. J. Hogg, “Evidence for activation of tissue factor by an allosteric disulfide bond,” Biochemistry, vol. 45, no. 39, pp. 12020–12028, 2006. View at Publisher · View at Google Scholar · View at Scopus
  175. H. Kaneko, V. V. Kakkar, and M. F. Scully, “Mercury compounds induce a rapid increase in procoagulant activity of monocyte-like U937 cells,” British Journal of Haematology, vol. 87, no. 1, pp. 87–93, 1994. View at Scopus
  176. J. Ahamed, H. H. Versteeg, M. Kerver et al., “Disulfide isomerization switches tissue factor from coagulation to cell signaling,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 38, pp. 13932–13937, 2006. View at Publisher · View at Google Scholar · View at Scopus
  177. A. Raturi and W. Ruf, “Effect of protein disulfide isomerase chaperone activity inhibition on tissue factor activity,” Journal of Thrombosis and Haemostasis, vol. 8, no. 8, pp. 1863–1865, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. H. H. Versteeg and W. Ruf, “Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity,” Journal of Biological Chemistry, vol. 282, no. 35, pp. 25416–25424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  179. C. Reinhardt, M. L. Von Brühl, D. Manukyan et al., “Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation,” Journal of Clinical Investigation, vol. 118, no. 3, pp. 1110–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  180. D. Manukyan, M. L. von Bruehl, S. Massberg, and B. Engelmann, “Protein disulfide isomerase as a trigger for tissue factor-dependent fibrin generation,” Thrombosis Research, vol. 122, supplement 1, pp. S19–S22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  181. H. Kothari, P. Sen, U. R. Pendurthi, and L. V. M. Rao, “Bovine protein disulfide isomerase-enhanced tissue factor coagulant function: is phospholipid contaminant in it the real culprit?” Blood, vol. 111, no. 6, pp. 3295–3296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. E. Persson, “Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor,” Thrombosis Research, vol. 123, no. 1, pp. 171–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  183. U. R. Pendurthi and L. V. M. Rao, “Response: tissue factor de-encryption: the cell model system,” Blood, vol. 112, no. 3, p. 913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  184. N. I. Popescu, C. Lupu, and F. Lupu, “Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure,” Blood, vol. 116, no. 6, pp. 993–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  185. N. I. Popescu, C. Lupu, and F. Lupu, “Role of PDI in regulating tissue factor: FVIIa activity,” Thrombosis Research, vol. 125, supplement 1, pp. S38–S41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  186. U. R. Pendurthi, S. Ghosh, S. K. Mandal, and L. V. M. Rao, “Tissue factor activation: is disulfide bond switching a regulatory mechanism?” Blood, vol. 110, no. 12, pp. 3900–3908, 2007. View at Publisher · View at Google Scholar · View at Scopus
  187. R. R. Bach and D. Monroe, “What is wrong with the allosteric disulfide bond hypothesis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 12, pp. 1997–1998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  188. H. Kothari, R. C. Nayak, L. V. M. Rao, and U. R. Pendurthi, “Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption,” Blood, vol. 115, no. 21, pp. 4273–4283, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. L. G. van den Hengel, B. Kocaturk, P. H. Reitsma, W. Ruf, and H. H. Versteeg, “Complete abolishment of coagulant activity in monomeric disulfide-deficient tissue factor,” Blood, vol. 118, pp. 3446–3448, 2011.
  190. W. Ruf and H. H. Versteeg, “Tissue factor mutated at the allosteric Cys186-Cys209 disulfide bond is severely impaired in decrypted procoagulant activity,” Blood, vol. 116, no. 3, pp. 500–501, 2010. View at Scopus
  191. B. Schmidt, L. Ho, and P. J. Hogg, “Allosteric disulfide bonds,” Biochemistry, vol. 45, no. 24, pp. 7429–7433, 2006. View at Publisher · View at Google Scholar · View at Scopus
  192. R. A. Bednar, W. B. Fried, Y. W. Lock, and B. Pramanik, “Chemical modification of chalcone isomerase by mercurials and tetrathionate. Evidence for a single cysteine residue in the active site,” Journal of Biological Chemistry, vol. 264, no. 24, pp. 14272–14276, 1989. View at Scopus
  193. G. J. Weber, A. P. Mehr, J. C. Sirota et al., “Mercury and zinc differentially inhibit shark and human CFTR orthologues: involvement of shark cysteine 102,” American Journal of Physiology, vol. 290, no. 3, pp. C793–C801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  194. F. Hatahet and L. W. Ruddock, “Substrate recognition by the protein disulfide isomerases,” FEBS Journal, vol. 274, no. 20, pp. 5223–5234, 2007. View at Publisher · View at Google Scholar · View at Scopus
  195. P. J. Hogg, “Disulfide bonds as switches for protein function,” Trends in Biochemical Sciences, vol. 28, no. 4, pp. 210–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  196. V. M. Chen and P. J. Hogg, “Allosteric disulfide bonds in thrombosis and thrombolysis,” Journal of Thrombosis and Haemostasis, vol. 4, no. 12, pp. 2533–2541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  197. K. Jurk, J. Lahav, H. Vana, M. F. Brodde, J. R. Nofer, and B. E. Kehrel, “Extracellular protein disulfide isomerase regulates feedback activation of platelet thrombin generation via modulation of coagulation factor binding,” Journal of Thrombosis and Haemostasis, vol. 9, pp. 2278–2290, 2011.
  198. D. W. Essex, A. Miller, M. Swiatkowska, and R. D. Feinman, “Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin,” Biochemistry, vol. 38, no. 32, pp. 10398–10405, 1999. View at Publisher · View at Google Scholar · View at Scopus
  199. L. G. Van den Hengel, S. Osanto, P. H. Reitsma, and H. Versteeg, “Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide,” Haematologica. In press.